Stuart Schreiber American chemist
Schreiber, Stuart L.
Schreiber, Stuart
Schreiber, Stuart, 1956-
VIAF ID: 58432161 (Personal)
Permalink: http://viaf.org/viaf/58432161
Preferred Forms
- 200 _ | ‡a Schreiber ‡b Stuart L.
- 100 1 _ ‡a Schreiber, Stuart
-
-
- 100 1 _ ‡a Schreiber, Stuart
-
- 100 1 _ ‡a Schreiber, Stuart L.
-
-
-
-
- 100 1 _ ‡a Schreiber, Stuart ‡d 1956-
-
- 100 0 _ ‡a Stuart Schreiber ‡c American chemist
4xx's: Alternate Name Forms (31)
Works
Title | Sources |
---|---|
Additions to C-X[pi]-Bonds | |
A chemical approach to understanding and controlling signal transduction, 1994: | |
Chemical biology from small molecules to systems biology and drug design | |
Comprehensive organic synthesis selectivity, strategy & efficiency in modern organic chemistry | |
Diversity-oriented synthesis : basics and applications in organic synthesis, drug discovery, and chemical bilogy | |
An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. | |
Kinase-Independent Small-Molecule Inhibition of JAK-STAT Signaling | |
Large-scale chemical dissection of mitochondrial function | |
Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map. | |
Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action Studies. | |
Macrocycloadditions leading to conformationally restricted small molecules | |
Metabolomic adaptations and correlates of survival to immune checkpoint blockade | |
Methylation of Histone H3 K4 Mediates Association of the Isw1p ATPase with Chromatin | |
Methylation of histone H3 Lys 4 in coding regions of active genes | |
Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway. | |
ML212: A small-molecule probe for investigating fluconazole resistance mechanisms in Candida albicans | |
ML238: An Antimalarial Small Molecule of a Unique Structural Class | |
Modular, stereocontrolled C-H/C-C activation of alkyl carboxylic acids | |
Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays | |
Multimodal small-molecule screening for human prion protein binders | |
Multiplex cytological profiling assay to measure diverse cellular states | |
NAMPT is the cellular target of STF-31-like small-molecule probes | |
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. | |
Niche-based screening identifies small-molecule inhibitors of leukemia stem cells | |
Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors. | |
A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold | |
An Oligomer-Based Approach to Skeletal Diversity in Small-Molecule Synthesis | |
Optimization of PDE3A Modulators for SLFN12-Dependent Cancer Cell Killing | |
Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles | |
Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements | |
Perturbational profiling of nanomaterial biologic activity | |
Phosphorylation-Inducing Chimeric Small Molecules | |
Piperazinyl quinolines as chemosensitizers to increase fluconazole susceptibility of Candida albicans clinical isolates | |
Plasticity of ether lipids promotes ferroptosis susceptibility and evasion | |
A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells | |
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints | |
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development | |
Quantifying fitness distributions and phenotypic relationships in recombinant yeast populations | |
Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections | |
Quantitative-proteomic comparison of alpha and Beta cells to uncover novel targets for lineage reprogramming | |
Real-Time Biological Annotation of Synthetic Compounds. | |
Recent achievements and current trajectories of diversity-oriented synthesis | |
Regulation of ferroptotic cancer cell death by GPX4 | |
Renal medullary carcinomas depend upon loss and are sensitive to proteasome inhibition | |
Revealing complex traits with small molecules and naturally recombinant yeast strains | |
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine | |
Ring-opening and ring-closing reactions of a shikimic acid-derived substrate leading to diverse small molecules | |
Rpd3p relocation mediates a transcriptional response to rapamycin in yeast | |
RWEN: response-weighted elastic net for prediction of chemosensitivity of cancer cell lines | |
Screen for Inhibitors of STK33 Kinase Activity | |
Screen for RAS-Selective Lethal Compounds and VDAC Ligands - Probe 2 | |
Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes. | |
Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles | |
Selective killing of cancer cells by a small molecule targeting the stress response to ROS | |
Selective modulation of autophagy, innate immunity, and adaptive immunity by small molecules | |
Short synthesis of skeletally and stereochemically diverse small molecules by coupling petasis condensation reactions to cyclization reactions | |
Signaling network model of chromatin | |
SIR1, an upstream component in auxin signaling identified by chemical genetics | |
A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase. | |
Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors | |
Small-molecule control of cytokine function: new opportunities for treating immune disorders | |
Small-molecule diversity using a skeletal transformation strategy | |
Small-molecule enhancers of autophagy modulate cellular disease phenotypes suggested by human genetics | |
Small-molecule fluorophores to detect cell-state switching in the context of high-throughput screening | |
Small-molecule inducers of insulin expression in pancreatic alpha-cells. | |
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma | |
A Small Molecule Inhibitor of Scavenger Receptor BI-mediated Lipid Uptake—Probe 2 | |
Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease. | |
Small molecule modulation of the human chromatid decatenation checkpoint | |
Small-molecule reagents for cellular pull-down experiments | |
Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells. | |
A small molecule suppressor of FK506 that targets the mitochondria and modulates ionic balance in Saccharomyces cerevisiae | |
Small-Molecule Suppressors of Cytokine-Induced beta-Cell Apoptosis. | |
Small-molecule targeting of brachyury transcription factor addiction in chordoma | |
Small molecules, big players: the National Cancer Institute's Initiative for Chemical Genetics. | |
Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. | |
Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles | |
SpectralNET--an application for spectral graph analysis and visualization | |
Stereochemical and skeletal diversity arising from amino propargylic alcohols | |
Stereospecific Palladium-Catalyzed C-H Arylation of Pyroglutamic Acid Derivatives at the C3 Position Enabled by 8-Aminoquinoline as a Directing Group | |
STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability |